Flagship explainer
What drives PHARMA-BIO SERV, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$100463 | FY2025 |
| |
| Income before tax | −$94260 | FY2025 |
|
| Operating income | −$637662 | FY2025 |
|
| $9M | FY2025 |
| |
| Ending assets | $13.7M | FY2025 |
|
| Beginning assets | $16.3M | FY2024 |
|
| $11.9M | FY2025 |
| |
| $13.7M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001654954-26-000710